Ex-Cel­gene CEO Bob Hug­in makes a leap back in­to biotech, join­ing an em­bat­tled Al­ler­gan's board

Bob Hug­in is back.

The for­mer Cel­gene CEO, who stepped down from the top job when the big biotech’s shares and rep were rid­ing high in the sad­dle, is jump­ing on­to the board at Al­ler­gan $AGN — which is slow­ly thaw­ing to the idea of re­vamp­ing its lead­er­ship struc­ture.

Un­der pres­sure from the hedge fund Ap­paloosa LP to di­vide the role of chair­man and CEO, Al­ler­gan’s board and CEO Brent Saun­ders used the news of Hug­in’s ar­rival on the board to note that the com­pa­ny will do that — even­tu­al­ly.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.